Chimeric Therapeutics (ASX:CHM) receives overwhelming support for $35M IPO
Chimeric Therapeutics (ASX:CHM) has received overwhelming support from investors, raising $35 million via an initial public…
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |
| ACS | ACCENT RESOURCES NL | 4.7¢ | 46.9% |
| DUB | DUBBER CORPORATION LIMITED | 2.0¢ | 42.9% |
| EPN | EPSILON HEALTHCARE LIMITED | 3.1¢ | 29.2% |
| MGL | MAGONTEC LIMITED | 20.0¢ | 21.6% |
| KAL | KALGOORLIE GOLD MINING LIMITED | 4.6¢ | 19.3% |
| CNJ | CONICO LTD | 1.1¢ | 15.4% |